Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Blood pressure response in 24 hours in patients with high blood pressure treated with two nifedipine formulations once a day

Abstract

A double-blind, comparative and prospective study with nifedipine once a day was undertaken, in patients with mild and moderate high blood pressure. Blood pressure was measured by mercury sphygmomanometer in two positions: resting and sitting at 3, 6 and 12 weeks of treatment and by ambulatory blood pressure monitoring (ABPM) over 24 h; both were carried out before and after the treatment and the uniformity in the pressure levels were obtained by means of the Smoothness Index. Fifty-four patients were included in the trial, 28 in the microgranules group and 26 in the osmotic pump group. These groups were similar at the baseline in age, gender, weight, height, diastolic and systolic blood pressure. The nifedipine microgranules group had a heart rate higher than the nifedipine osmotic pump group at baseline (XM = 75.58 vs XB = 70.75). Blood pressure decreased significantly during the first 3 weeks; 85% in the microgranules group and 75% in the osmotic pump group reached a blood pressure 140/90 mm Hg at the end of the study. Three patients in the microgranules group and two in the osmotic pump group required an additional antihypertensive drug. In both groups, the average blood pressure over 24 h was lowered without differences between groups. A decrease was induced in the heart rate in both groups which reached a marginal statistical significance in the microgranules nifedipine group. No changes were induced in the laboratory tests; two patients in the microgranules (8%) nifedipine group and five in the nifedipine osmotic pump group, adverse effects were observed, of which only one in each group required stopping the treatment.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 3
Figure 2
Figure 1
Figure 5
Figure 4
Figure 5

Similar content being viewed by others

References

  1. Guidelines Subcommittee 1999 World Health Organization-International Society of Hypertension. Guidelines for the Management of Hypertension J Hypertens 1999 17: 151–183

  2. Brawnwald E . Mechanism of action of calcium-channel blocking agents N Engl J Med 1983 307: 1618–1627

    Google Scholar 

  3. Kaplan NM . Calcium entry blockers in the treatment of hypertension JAMA 1989 262: 817–823

    Article  CAS  PubMed  Google Scholar 

  4. Frishman WH, Charlap S, Michelson EL . Calcium-channel blockers in systemic hypertension Am JCardiol 1986 58: 157–160

    Article  CAS  Google Scholar 

  5. Chung M, Reitberg DP, Gaffney M . Clinical pharmacokinetics of nifedipine gastrointestinal system: a controlled-release formulation of nifedipine Am J Med 1987 83 (Suppl 3): 10–14

    Article  Google Scholar 

  6. Salazar A, Arocha I . Antihypertensive efficacy and tolerance of the osmotic formulation of nifedipine: Venezuelan Multicenter Study Acta Clinica (Bayer) 1993 4: 11–15

    Google Scholar 

  7. Scientific Technical Report of a new nifedipine to be administered every 24 hours Laboratorios Leti, Venezuela 1997

  8. Coll Y, Rizzo A . Pharmacokinetics assessment of repeated doses of microgranules nifedipine 30 mg Tensomax ® Scientific Higher Board, Barcelona, Spain 1993

    Google Scholar 

  9. Waiters D et al. A controlled clinical trial to assess the effect of a calcium channel blocker on the progression of coronary atherosclerosis Circulation 1990 821: 940–953

    Google Scholar 

  10. Lichtlen PR et al on behalf of the INTAC GroupInvestigator. Retardation of angiographic progression of coronary artery disease by nifedipine. Results of the International Nifedipine Trial on Antiatherosclerotic Therapy (INTAC) Lancet 1990 335: 1109–1103

    Article  CAS  PubMed  Google Scholar 

  11. Collet H, Uzcategui I, Freites M, Gonzalez M . Efficacy and tolerance of a new nifedipine formulation to be administered once a day in the form of micro particles Arch Ven Farm Therap 1997 16: 78–81

    Google Scholar 

  12. Roa E et al. Blood pressure profiles in 24 hours inpatients with high blood pressure treated with two nifedipine formulations. Preliminary report TEMATICA 2000 1: 16–19

    Google Scholar 

  13. Ruilope L . New prospects in the treatment of artery hypertension (Results of the INSIGHT). Conference within the framework of the XIX South American Congress of Cardiology. Caracas, 9 June 2000

  14. Schmieder R, Martus P, Klingbeil A . Reversal of left ventricular hypertrophy in essential hypertension JAMA 1996 275: 1507–1513

    Article  CAS  PubMed  Google Scholar 

  15. Yurenev AP, Dyakonova HG, Novkov ID . Management of essential hypertension inpatients with different degrees of left ventricular hypertrophy Am J Hypertens 1992 5: 5182–5189

    Google Scholar 

  16. Hansson L, Zanchetti A, Carruthers G, Dablof B . Effects of intensive blood pressure lowering and low dose aspirin inpatients with hypertension: principal result of the Hypertension Optimal Treatment (HOT) randomized trial Lancet 1998 351: 1755–1762

    Article  CAS  PubMed  Google Scholar 

  17. Frishman WH, Katz B . Controlled-release drugs delivery systems in cardiovascular disease treatment. In: Frishman WH, Sonmenblick ED (eds) Cardiovascular Pharmacotherapeutics McGraw Hill: New York 1997 1363–1374

    Google Scholar 

  18. White WB et al. Comparison of effects of controlled onset extended release verapamil at bedtime and nifidepine gastrointestinal therapeutic system on arising on early morning blood pressure, heart rate and the heart rate-blood pressure product Am J Cardiol 1998 81: 424–431

    Article  CAS  PubMed  Google Scholar 

  19. White WB . Analysis of ambulatory blood pressure data in antihypertensive drug trials J Hypertens 1991 21 (Suppl 1): S27–S32

    Google Scholar 

Download references

Acknowledgements

The authors are grateful to Mrs Carmen Zulay Ibarra for her collaboration in performing the statistical analysis.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rodríguez-Roa, E., Octavio, A., Mayorca, E. et al. Blood pressure response in 24 hours in patients with high blood pressure treated with two nifedipine formulations once a day. J Hum Hypertens 16 (Suppl 1), S151–S155 (2002). https://doi.org/10.1038/sj.jhh.1001363

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jhh.1001363

Keywords

Search

Quick links